BIOQUAL Insights
Financials
Investing for a Better Future
Investor Relations
BIOQUAL, Inc. is a public company traded on the OTC Markets Group – Symbol BIOQ.
BIOQUAL, Inc.’s Transfer Agent:
Computershare, Inc.
480 Washington Boulevard
Jersey City, New Jersey 07310
www.computershare.com
Contact
Hanne Andersen Elyard
President / Chief Scientific Officer
BIOQUAL, Inc.
Phone: (240) 404-7654
Financial News
2026
BIOQUAL News Release April 21, 2026
BIOQUAL Presents Unaudited Financial Results and Management’s Discussion & Analysis for FY 2026 Third Quarter Ended February 28, 2026
BIOQUAL News Release January 22, 2026
BIOQUAL presents Unaudited Financial Statements and Management’s Discussion & Analysis for the quarterly period ended November 30, 2025
2025
BIOQUAL News Release October 21, 2025
BIOQUAL Presents Unaudited Financial Statements and Management’s Discussion & Analysis for the quarterly period ended August 31, 2025
BIOQUAL Presents Financial Results for Fiscal Year 2025
BIOQUAL Presents Financial statements, May 31, 2025 and 2024
BIOQUAL Presents Unaudited Financial Results and Management’s Discussion and Analysis for FY 2025 Third Quarter Ending Feb. 28, 2025
2022
BIOQUAL Announces Results from 2022 Meeting of Stockholders [Updated 10/28/22]
BIOQUAL Dividend News Release 9-27-2
BIOQUAL Presents Audited Financial Statements for Fiscal Year 2022
BIOQUAL Presents Financial Results for FY 2022 Third Quarter [Updated 04/21/22]
BIOQUAL and Subsidiary Presents Financial Results for Second Quarter of Fiscal Year 2022